Effects in the control of edema of the papilla of vater by epinephrine saline irrigation after endoscopic retrograde cholangiopancreatography in an endoscopy center in Japan, 2003 to 2007: Exploratory retrospective analysis to evaluate the characteristics of eligible patients with a focus on serum amylase levels

Internal Medicine

Volumn 48, Issue 12, 2009, Pages 945-952

  Nakaji, Konosuke ^a   Suzumura, Shigeo ^b   Nakae, Yukinori ^a   Kojima, Kensaku ^a   Kumamoto, Mitsutaka ^a   Kozu, Tomonaga ^a  

^a Aishinkai Nakae Hospital   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Effects; Endoscopic retrograde cholangiopancreatography; Epinephrine saline irrigation; Pancreatitis; Prevention

Indexed keywords

ADRENALIN; AMYLASE; SODIUM CHLORIDE;

ADULT; AGED; AMYLASE BLOOD LEVEL; ARTICLE; CANNULATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EXPLANATORY VARIABLE; FEMALE; HUMAN; LAVAGE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PANCREAS DUCT; PANCREATITIS; PROTEIN URINE LEVEL; RISK FACTOR; SEX DIFFERENCE; VATER PAPILLA;

ADRENERGIC AGONISTS; ADULT; AGED; AGED, 80 AND OVER; AMPULLA OF VATER; AMYLASES; CASE-CONTROL STUDIES; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; COMMON BILE DUCT DISEASES; EDEMA; EPINEPHRINE; FEMALE; HUMANS; IRRIGATION; JAPAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PANCREATITIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 67650082378     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.1705     Document Type: Article

References (34)

1. Ohashi A, Tamada K, Tomiyama T, et al. Epinephrine irrigation for the prevention of pancreatic damage after endoscopic balloon sphincteroplasty. J Gastroenterol Hepatol 16: 568-571, 2001.
2. Hayakawa T, Naruse S, Kitagawa M, et al. Preventative measures of occasional endoscopic retrograde cholangiopancreatography (ERCP)-related conditions: especially post-ERCP acute pancreatitis. Suizo (Journal of the Japan Pancreas Society) 14: 455-462, 1999 (in Japanese).
3. Freeman ML, DiSario JA, Nelson DB, et al. Risk factors for post-ERCP pancreatitis. Gastrointest Endosc 54: 425-434, 2001.
4. Andriulli A, Leandro G, Federici T, et al. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP. Gatrointest Endosc 65: 624-632, 2007.
5. Cavallini G, Tittobello A, Frulloni L, et al. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangoipancreatography. N England J Med 335: 919-923, 1996.
6. Kapetanous D, Kokozidis G, Kinigopulou P, et al. The value of serum amylase and elastase measurements in prediction of post-ERCP acute pancreatitis. Hepato-Gastroenterology 54: 556-560, 2007.
7. Mallery JS, Baron TH, Dominitz JA, et al. Complications of ERCP. Gastrointest Endosc 57: 633-638, 2003.
8. Tsujino T, Omata M, Kawabe T. Prevention of post-ERCP pancreatitis by UTI: Evidence and medical economic approach. Shinsyu to Meneki (Surgical Trauma and Immunological Responses) 16: 40-43, 2007 (in Japanese).
9. Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 37: 383-393, 1991.
10. Dimitrios A, George KA, Dimitrios G, et al. Can somatostatin prevent post-ERCP pancreatitis? randomized controlled trial. J Gastroenterol Hepatol 19: 278-282, 2004.
11. Poon RT, Yeung C, Liu CL, et al. Intravenus bols somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomized controlled trial. Gut 52: 1768-1773, 2003.
12. Xiong GS, Wu SM, Zhng XW, Ge ZZ. Clinical trial of gabaxate in the prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis. Brazillian Journal of Medical and Biological Research 39: 85-90, 2006.
13. Zheng M, Chen Y, Yang X, Li J, Zhng Y, Zeng Q. Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials. BMC Gastroenterology 7: 6, 2007.
14. Tsujino T, Kawabe T, Omata M. Antiproteases in preventing post-ERCP acute pancreatitis. JOP 8: 509-517, 2007.
15. Thomopoulous KC, Pagoni NaA, Vagenas KA, Margaritis VG, Theocharis GI, Nikolopoulou VN. Twenty-four hour prophylaxis with increased dosage of octeotide reduces the incidence of post-ERCP pancreatitis. Gastrointest Endosc 64: 726-731, 2006.
16. Li ZS, Pan X, Zhang WJ, et al. Effect of octreotide administration in prophylaxis of post-ERCP pancreatitis and hyperamylasemia: a multicenter, placebo controlled, randomized clinical trial. Am J Gastroenterol 102: 46-51, 2007.
17. Katsinelos P, Kountouras J, Chatzis J, et al. High-dose allopurinol for prevention of post-ERCP pancreatitis: a prospective randomized double-blind controlled trial. Gastrointest Endosc 61: 407-415, 2005.
18. Budzyska A, Marek T, Nowak A, Kaczor R, Nowakowska-Dulawa E. A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in prevention of ERCP-induced pancreatitis. Endoscopy 33: 766-772, 2001.
19. Kawanngern K, Tiyapattanaputi P, Wantipukdeedecha M, Navicharern P. Can a single dose corticosteroid reduce the incidence of post-ERCP panceratitis?: a randomized prospective control study. J Med Assoc Thai 88: 42-45, 2005.
20. He ZJ, Winston JH, Yusuf TE, et al. Intraductal administration of an NK1 receptor antagonist attenuates the inflammatory response to retrograde infusion of radiological contrast in rats: implication for the pathogenesis and prevention of ERCP-induced pancreatitis. Panaceas 27: e13-e17, 2003.
21. Sotoudehmanesh R, Khatibian M, Kolahdoozan S, Ainechi S, Malboobaf R, Nouraie M. Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP. Am J Gastroenterol 102: 978-983, 2007.
22. Wagh MS, Sherman S. Indomethacin for post-ERCP pancreatitis prophylaxis another attempt at the Holy Grail. Am J Gastroenterol 102: 984-986, 2007.
23. Xiong GS, Wu SM, Wang ZH, Mo JZ, Xiao SD. Effect of thalidomide in experimental models of post-endoscopic cholangiopancreatography pancreatitis. J Gastroenterol Hepatol 22: 371-376, 2007.
24. Gorelick A, Barnett J, Chey W, Anderson M, Elta G. Botulinum toxin injection after billiary sphincterotomy. Endoscopy 36: 170-173, 2004.
25. Shwartz JJ, Lew RJ, Ahmad NA, et al. The effect of lidocaine sprayed on the major duodenal papilla on frequency of post-ERCP pancreatitis. Gastrointest Endosc 59: 179-184, 2004.
26. Katsinelos P, Kountouras J, Paroutoglou G, Beltsis A, Mimidis K, Zavos C. Intravenous N-acetylcysteine does not prevent post-ERCP panceatitis. Gastrointest Endosc 62: 105-111, 2005.
27. Milewski J, Rydzewska G, Degowska M, Kierzkiewicz M, Rydzewski A. N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis. World J Gastroenterol 12: 3751-3755, 2006.
28. Tujino T, Komatsu Y, Isayama H, et al. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial. Clinical Gastroenterology and Hepatology 3: 376-383, 2005.
29. Lavy A, Karban A, Suissa A, Yassin K, Hermesh I, Ben-Amotz A. Natural β-carotene for the prevention of post-ERCP panceratitis. Panaceas 29: e45-e50, 2004.
30. Hackert T, Werner J, Gebhard MM, Klar E. Effect of heparin in experimental models of acute panceatitis and post-ERCP panceatitis. Surgery 135: 131-138, 2004.
31. Rabenstein T, Fischer B, Wiessner V, et al. Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis. Gastrointest Endosc 59: 606-613, 2004.
32. Prat F, Amaris J, Ducot B, et al. Nifedipine for prevention of post-ERCP panceatitis: a prospective double-blinded randomized study. Gastrointest Endosc 56: 202-208, 2002.
33. Lella F, Bagnolo F, Colombo E, et al. A simple way of avoiding post-ERCP pancreatitis. Gatrointest Endosc 59: 830-834, 2004.
34. Pauweis M, Duchmann JC, Yzet T, Capron JP. Duodenal hematoma, acute pancreatitis, and hemoperitoneum after endoscopic hemostasis for duodenal ulcer. Gastroenterol Clin Biol 22: 462-564, 1998.